Overview
This study aims to evaluate whether geographic mismatch is an independent predictor of short-term major adverse cardiovascular events following long coronary stent implantation.
Description
Coronary artery disease (CAD) remains one of the leading causes of morbidity and mortality worldwide despite substantial advances in preventive strategies, pharmacological therapy, and coronary revascularization techniques.
Percutaneous coronary intervention (PCI) has become the standard treatment for many patients with obstructive CAD and has significantly improved both short- and long-term clinical outcomes.
Several clinical, angiographic, and procedural factors have been identified as predictors of adverse outcomes following PCI, including advanced age, diabetes mellitus, chronic kidney disease, left ventricular dysfunction, lesion complexity, and total stent length.
Eligibility
Inclusion Criteria:
- Age ≥18 years old.
- Both sexes.
- Patients undergo percutaneous coronary intervention (PCI) with successful implantation of a drug-eluting stent (DES) measuring ≥38 mm in length.
- Successful stent deployment with discharge after PCI.
Exclusion Criteria:
- Bare-metal stent (BMS) implantation.
- Cardiogenic shock at presentation.
- In-stent restenosis lesions.
- Previous stent implantation in the target coronary segment.
- Life expectancy \<6 months due to non-cardiac causes.
- Incomplete clinical or geographic data.
- Patients lost to follow-up immediately after hospital discharge.
